In a research report published earlier today, Morgan Stanley commented that it is not as confident in Teleflex's
TFX strategy as management is.
According to Morgan Stanley, “Management meetings suggest confidence in the top line and commitment to investing in product differentiation. Teleflex's ability to reach 7% sales growth and 5% R&D spending long-term is less clear, but we are not convinced those levels are necessary to drive value.”
Morgan Stanley maintains its Equal-weight rating on Teleflex, which closed yesterday at $61.24.
Loading...
Loading...
TFXTeleflex Inc
$126.490.98%
Edge Rankings
Momentum
13.39
Growth
36.76
Quality
0.92
Value
27.75
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in